1 Introduction Patients with acute kidney injury (AKI) and those receiving continuous kidney replacement therapy (CKRT, formerly known as continuous renal replacement therapy, or CRRT) represent a vulnerable group with a high risk of mortality [1-3]. These patients frequently have altered drug pharmacokinetics (PK) due to both alterations in physiology from critical illness itself and from the extracorporeal drug device [4, 5].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Danica
Contact Danica, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack